A Study Evaluating Safety and Therapeutic Activity of ANV419 in Patients With Advanced Solid Tumors.
Status:
Recruiting
Trial end date:
2023-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the safety and efficacy of ANV419 (single agent and
combination therapy) in patients with relapsed/refractory advanced solid tumors.